» Authors » Irina Turchin

Irina Turchin

Explore the profile of Irina Turchin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Park M, Sibbald C, Keeling C, Croitoru D, Veillette H, Lara-Corrales I, et al.
J Cutan Med Surg . 2025 Jan; :12034754251316302. PMID: 39882948
No abstract available.
2.
Prajapati V, Lynde C, Gooderham M, Hong H, Kirchhof M, Lansang P, et al.
J Eur Acad Dermatol Venereol . 2024 Sep; 39(3):487-497. PMID: 39239977
Generalized pustular psoriasis (GPP) is a rare, chronic skin disease, characterized by widespread pustules and erythema, often accompanied with systemic signs and symptoms. GPP flares occur episodically but may be...
3.
Kirchhof M, Prajapati V, Gooderham M, Hong C, Lynde C, Maari C, et al.
Dermatol Ther (Heidelb) . 2024 Aug; 14(9):2653-2668. PMID: 39115712
Oral Janus kinase inhibitors (JAKi), a class of advanced targeted systemic therapy, have demonstrated efficacy and safety in the treatment of moderate-to-severe atopic dermatitis (AD). Like other small molecules, oral...
4.
Guenther L, Turchin I, Vender R, Albrecht L, Maari C, Yanofsky H, et al.
Dermatol Ther (Heidelb) . 2024 Jun; 14(7):1917-1928. PMID: 38916719
Introduction: An expert panel of Canadian dermatologists was assembled to develop consensus statements regarding the current landscape of topical therapies for plaque psoriasis and the place in therapy of the...
5.
Lee E, Turchin I, Chan A, Beecker J, Bissonnette R, Catherall H, et al.
J Cutan Med Surg . 2024 Mar; 28(4):387-388. PMID: 38504147
No abstract available.
6.
Gooderham M, Bissonnette R, Kalia S, Papp K, Guenther L, Gulliver W, et al.
J Cutan Med Surg . 2023 Aug; 27(6):594-600. PMID: 37571829
Background: The Psoriasis Longitudinal Assessment and Registry (PSOLAR) is a global, prospective, longitudinal, disease-based registry. It serves as a post-marketing safety commitment with a focus on patients with moderate to...
7.
Lagace F, Noorah B, Conte S, Mija L, Chang J, Cattelan L, et al.
Cancers (Basel) . 2023 Aug; 15(15). PMID: 37568569
Background: The incidence of cutaneous melanoma (CM) is increasing at an alarming rate in Canada and elsewhere around the world. Significant regional differences in CM incidence have been identified in...
8.
Papp K, Melosky B, Sehdev S, Hotte S, Beecker J, Kirchhof M, et al.
Dermatol Ther (Heidelb) . 2023 Jul; 13(8):1889-1890. PMID: 37410207
No abstract available.
9.
Kashetsky N, Turchin I
Skin Therapy Lett . 2023 Jun; 28(3):8-13. PMID: 37339609
As systemic administration of Janus kinase-inhibitors is associated with safety concerns, local alternatives, such as topical ruxolitinib, have been developed. This review summarizes utilization of topical ruxolitinib in dermatology. A...
10.
Yeung J, Gooderham M, Hong H, Lynde C, Prajapati V, Lansang P, et al.
J Am Acad Dermatol . 2023 Apr; 89(2):372-375. PMID: 37074241
No abstract available.